Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Oragenics Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 22 | −7 |
| Shares | 9.12M | 9.40M | +280.8K (+3.1%) |
| Value | $8.27M | $6.63M | −$1.64M (−19.8%) |
New holders (6)
Institutions that held Oragenics Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 454,325 | $321.0K | 0.00% |
| Renaissance Technologies LLC | 252,564 | $178.0K | 0.00% |
| Millennium Management LLC | 26,855 | $19.0K | 0.00% |
| UBS Group AG | 4,499 | $3.00K | 0.00% |
| Bank of America Corp | 46 | $0 | 0.00% |
| Evermay Wealth Management LLC | 120 | $0 | 0.00% |
Sold out (13)
Institutions that held Oragenics Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citadel Advisors LLC | 370,521 | $336.0K |
| Private Wealth Advisors | 56,824 | $52.0K |
| Gsa Capital Partners LLP | 48,767 | $44.0K |
| Charles Schwab Investment Management Inc | 42,545 | $39.0K |
| Jane Street Group, LLC | 33,015 | $30.0K |
| Tower Research Capital LLC (TRC) | 29,077 | $26.0K |
| LPL Financial LLC | 20,500 | $19.0K |
| Two Sigma Securities, LLC | 10,686 | $10.0K |
| Wealthcare Advisory Partners LLC | 5,000 | $5.00K |
| Captrust Financial Advisors | 3,000 | $3.00K |
| Barclays PLC | 880 | $1.00K |
| Certified Advisory Corp | 1 | $0 |
| Global Retirement Partners, LLC | 500 | $0 |